Roxadustat for the treatment of anemia in patients with lower‐risk myelodysplastic syndrome: Open‐label, dose‐selection, lead‐in stage of a phase 3 study.

Autor: Henry, David H., Glaspy, John, Harrup, Rosemary, Mittelman, Moshe, Zhou, Amy, Carraway, Hetty E., Bradley, Charles, Saha, Gopal, Modelska, Katharina, Bartels, Pamela, Leong, Robert, Yu, Kin‐Hung P.
Zdroj: American Journal of Hematology; Feb2022, Vol. 97 Issue 2, p174-184, 11p
Databáze: Complementary Index
Externí odkaz: